Select Medical (NYSE:SEM) Sees Strong Trading Volume – Here’s What Happened

Select Medical Holdings Corporation (NYSE:SEM) saw strong trading volume on Thursday . 2,672,986 shares traded hands during trading, an increase of 51% from the previous session’s volume of 1,767,876 shares.The stock last traded at $16.5450 and had previously closed at $16.52.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on the stock. Zacks Research upgraded shares of Select Medical from a “strong sell” rating to a “hold” rating in a research note on Monday, May 4th. Mizuho restated a “neutral” rating and set a $16.50 price target (down from $17.00) on shares of Select Medical in a research note on Tuesday, May 12th. Weiss Ratings upgraded shares of Select Medical from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, February 20th. Benchmark lowered shares of Select Medical from a “buy” rating to a “hold” rating in a research note on Wednesday, March 4th. Finally, Royal Bank Of Canada restated a “sector perform” rating and set a $16.50 price target (down from $19.00) on shares of Select Medical in a research note on Tuesday, March 3rd. One investment analyst has rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat.com, Select Medical currently has an average rating of “Hold” and a consensus price target of $15.50.

Select Medical Stock Performance

The company’s fifty day moving average is $16.37 and its 200 day moving average is $15.45. The company has a market capitalization of $2.05 billion, a P/E ratio of 15.61, a P/E/G ratio of 0.95 and a beta of 1.02. The company has a current ratio of 1.15, a quick ratio of 1.15 and a debt-to-equity ratio of 0.88.

Select Medical (NYSE:SEM) last released its quarterly earnings data on Thursday, April 30th. The health services provider reported $0.36 EPS for the quarter, missing the consensus estimate of $0.43 by ($0.07). The business had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.41 billion. Select Medical had a return on equity of 6.62% and a net margin of 2.42%.The firm’s quarterly revenue was up 5.0% on a year-over-year basis. During the same period last year, the business posted $0.44 earnings per share. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. As a group, equities analysts anticipate that Select Medical Holdings Corporation will post 1.26 earnings per share for the current year.

Select Medical Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 28th. Investors of record on Thursday, May 14th will be issued a $0.0625 dividend. The ex-dividend date of this dividend is Thursday, May 14th. This represents a $0.25 annualized dividend and a yield of 1.5%. Select Medical’s dividend payout ratio (DPR) is 23.58%.

Select Medical declared that its board has approved a stock buyback program on Thursday, February 19th that allows the company to repurchase $1.00 billion in shares. This repurchase authorization allows the health services provider to purchase up to 49.5% of its shares through open market purchases. Shares repurchase programs are often an indication that the company’s management believes its shares are undervalued.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. Quarry LP bought a new position in Select Medical in the 4th quarter valued at $26,000. Quantbot Technologies LP bought a new position in Select Medical in the 3rd quarter valued at $27,000. Caitong International Asset Management Co. Ltd bought a new position in Select Medical in the 4th quarter valued at $28,000. Hantz Financial Services Inc. boosted its holdings in Select Medical by 214.7% in the 4th quarter. Hantz Financial Services Inc. now owns 2,549 shares of the health services provider’s stock valued at $38,000 after purchasing an additional 1,739 shares during the period. Finally, Smartleaf Asset Management LLC boosted its holdings in Select Medical by 37.8% in the 4th quarter. Smartleaf Asset Management LLC now owns 2,870 shares of the health services provider’s stock valued at $43,000 after purchasing an additional 788 shares during the period. 89.48% of the stock is owned by institutional investors.

About Select Medical

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.